Military Medicine
Cure8 research brief
Why This Matters
Changes to aeromedical waiver policy could allow some aviators with well-controlled Crohn’s disease to remain or return to flight duty, affecting careers and military readiness while aiming to preserve safety.
Who Should Pay Attention
Military and civilian aviators with Crohn’s disease; aeromedical clinicians and military medical policymakers; gastroenterologists advising aviators.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper reviews how advances in surgery, medications, nutrition, and monitoring have improved outcomes for many people with Crohn’s disease and suggests aeromedical guidance (ARWG Section 7.2) be revised to permit structured waiver consideration.
It emphasizes requirements such as documented clinical remission, absence of aeromedically significant complications, and stability on therapy before return-to-flight is approved.
The proposal preserves safety by recommending continued grounding during active disease, after treatment changes, or following events that increase the risk of incapacitation, with reassessment before reinstating flight status.
The article is framed as an evidence-informed policy proposal specific to Naval Aviation medical standards rather than new clinical trial data; it focuses on aligning waiver practices with contemporary gastroenterology care.
Keep In Mind
The article is an evidence-informed policy proposal (abstract-level) and not a clinical trial. Recommendations focus on selected individuals with documented remission and objective disease control; temporary grounding remains recommended after diagnosis, flares, or medication changes.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMilitary Medicine
AuthorsJake Cresta, J. Kwan, Stephanie Tamayo +1 more
InstitutionWalter Reed National Military Medical Center
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedJul 17, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
Access and insurance issues can delay IBD medications and lead patients to skip doses or make financial sacrifices. That can worsen health and daily life, so this affects many people with Crohn’s disease and ulcerative...
VIDEO: Copay, patient access programs can help combat costs for patients with Crohn’s
High medication costs and insurance rules can change what treatments a person with Crohn’s can actually get. Knowing about copay assistance and patient-access programs can lower or eliminate out-of-pocket cost and help...
IBD Leads to Financial Sacrifices, Survey Shows — 5 Ways to Manage Costs Now
The article reports that many people with IBD face unaffordable care and medication access problems that can lead to nonadherence and worse health. It offers practical steps to manage costs now and calls for policy...